Clinical Trial Update: Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized, placebo-controlled study evaluating solriamfetol's effects on cognitive health in adults with obstructive sleep apnea has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Sunosi (solriamfetol) (solriamfetol)

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Excessive Daytime Sleepiness, Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED | Results posted: 2026-01-26